GL1X · GenesisL1 explorer

MolNFT v1 · #181244 · protein

Crystal structure of bptf bromodomain in complex with inhibitor pdy-3- 077

7LP0 · Nucleosome-remodeling factor subunit bptf: “Crystal structure of bptf bromodomain in complex with inhibitor pdy-3- 077”. X-ray diffraction, 1 ligand (P2L), 3 pockets (best druggability 0.53). MolNFT v1 #181244 on GenesisL1: 3D…

PDB
7LP0
Type
protein
Length
226 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nucleosome-remodeling factor subunit bptf
UniProt
Q12830
Ligands
P2L
Pockets
3 · best druggability 0.53

Structure

x-ray diffraction · 2 distinct chains · 69% helix, 1% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANucleosome-remodeling factor subunit bptfprotein11168% helix, 0% strandQ12830
BNucleosome-remodeling factor subunit bptfprotein11570% helix, 2% strandQ12830

Ligands and binding sites

  • P2L · 4-chlorol-2-methyl-5-[[(3~{R})-1-methylpiperidin-3-yl]amino]pyridazin-3-one · ligand · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A, B
  • DMS · Dimethyl sulfoxide · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1760.530.8519P2L
22130.510.7632EDO
3840.500.8318P2L

Interfaces

1 interface between chains.

  • A–B · 322 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 7LP0 · Crystal structure of BPTF bromodomain in complex with inhibitor Pdy-3-077 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.